An unusual response to 5‐azacitidine by a patient with chronic myelomonocytic leukemia
Key Clinical Message Hypomethylating agents may be useful in some but not all cases of myelodysplastic syndromes. In some versions of these conditions, this treatment may yield deleterious results. Abstract Chronic myelomonocytic leukemia (CMML) is considered to be a heterogeneous group of hematopoi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.7748 |